Monster Beverage
MNST
$96.38
-1.30%
Monster Beverage Corporation is a leading player in the non-alcoholic ready-to-drink beverage market, primarily known for its Monster Energy drink brand and a portfolio that includes Monster Ultra, Java Monster, Reign, and Bang. As the dominant force in the energy drink category, Monster leverages its strong brand equity and a strategic 20-year distribution agreement with Coca-Cola, which also holds a 20% stake in the company. The current investor narrative centers on Monster's ability to sustain double-digit revenue growth amid intensifying competition from newer entrants like Celsius, while also navigating margin pressures from input costs and its expansion into the alcohol beverage segment following a 2022 craft brewery acquisition.…
MNST
Monster Beverage
$96.38
Related headlines
Investment Opinion: Should I buy MNST Today?
Rating: Hold. Monster Beverage is a high-quality growth company with accelerating revenue and strong margins, but its premium valuation and modest analyst upside suggest limited near-term appreciation. The consensus 'Buy' rating and average target of $95.70 imply only 2.4% upside, making the risk/reward less attractive for new positions.
Supporting Evidence: Revenue grew 26.89% YoY in Q1 2026, well above the industry average. Net margin of 24.2% and operating margin of 31.02% demonstrate strong profitability. Free cash flow of $2.07B provides financial flexibility. The forward P/E of 36.02x is below the trailing 39.32x, indicating expected earnings growth. However, the PEG ratio of 1.31x suggests the stock is reasonably but not cheaply valued relative to growth.
Risks & Conditions: The biggest risks are competitive pressure from Celsius and potential gross margin erosion. This Hold would upgrade to Buy if the stock pulls back to a P/E below 30x or if revenue growth sustains above 20% for multiple quarters. It would downgrade to Sell if growth decelerates below 10% or if gross margins fall below 50%. Overall, MNST appears fairly valued relative to its growth and profitability, but not undervalued.
Sign up to view all
MNST 12-Month Price Forecast
Monster Beverage is a high-quality growth company with accelerating revenue and strong margins, but its premium valuation and modest analyst upside suggest limited near-term appreciation. The base case of 15-18% growth and stable margins is most likely, leading to a neutral stance. Upside catalysts include sustained growth above 20% and margin expansion, while downside risks include competitive pressure from Celsius and multiple compression. The stance would upgrade to bullish if revenue growth exceeds 20% for two consecutive quarters or if the P/E compresses below 30x, and downgrade to bearish if growth falls below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $96.39 and implied upside of +0.0% versus the current price.
Average Target
$96.39
0 analysts
Implied Upside
+0.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $113
Analyst target range
Monster Beverage is covered by 23 analysts, with a consensus recommendation of 'Buy' (mean recommendation 2.12 on a 1-5 scale where 1 is Strong Buy). The average target price is $95.70, implying a modest 2.4% upside from the current price of $93.49. The distribution leans bullish, with recent ratings from Citigroup (Buy), Wells Fargo (Overweight), and Morgan Stanley (Overweight), while JP Morgan and UBS maintain Neutral. The consensus is cautiously bullish, with limited upside expected near term. The target range spans from a low of $70.00 to a high of $113.00. The high target of $113 implies a 20.9% upside and likely assumes continued market share gains and margin expansion. The low target of $70 suggests a 25.1% downside, potentially pricing in competitive pressures from Celsius or a slowdown in energy drink demand. The wide spread ($43) indicates significant uncertainty about the stock's future performance. Recent analyst actions have been predominantly positive, with upgrades from Rothschild & Co (Neutral to Buy) and reaffirmations of Overweight/Outperform ratings from multiple firms, suggesting confidence in the company's trajectory despite the narrow average upside.
Drowning in data?
Find the real signal!
Bulls vs Bears: MNST Investment Factors
Monster Beverage presents a compelling growth story with accelerating revenue, expanding margins, and a fortress balance sheet. The bull case is supported by 26.89% revenue growth, zero debt, and strong analyst sentiment. However, the stock trades at a premium valuation (39.32x P/E vs. industry 22x) and faces intense competition from Celsius. The single most important tension is whether Monster can sustain its double-digit growth trajectory amid competitive pressures; if growth decelerates, the premium multiple could compress significantly. Currently, the bull case has stronger evidence given the accelerating growth and financial strength, but investors should monitor competitive dynamics closely.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 26.89% YoY to $2.353B, accelerating from 13.9% in Q1 2025. This outpaces the beverage industry average of ~8%, demonstrating strong market share gains and brand momentum.
- Pristine Balance Sheet: Monster has zero debt (debt-to-equity ratio of 0) and a current ratio of 3.70, providing ample liquidity. Free cash flow TTM is $2.07B, enabling internal funding for growth and potential acquisitions.
- Expanding Profit Margins: Operating margin improved to 31.02% in Q1 2026 from 30.72% a year ago, while net margin rose to 24.2% from 23.9%. This reflects operating leverage and pricing power despite input cost pressures.
- Strong Analyst Consensus: 23 analysts rate MNST a 'Buy' with a mean recommendation of 2.12 (1=Strong Buy). Recent upgrades from Rothschild & Co (Neutral to Buy) and reaffirmations from Citigroup, Wells Fargo, and Morgan Stanley signal confidence.
Bearish
- Premium Valuation vs. Peers: Trailing P/E of 39.32x is a 79% premium to the beverage industry median of ~22x. While justified by growth, any slowdown could lead to multiple compression and significant downside.
- Intense Competition from Celsius: Celsius offers higher growth potential and is aggressively taking market share in the energy drink category. A recent Motley Fool article highlights Celsius as a threat to Monster's dominance.
- Modest Analyst Upside: Average analyst target of $95.70 implies only 2.4% upside from the current price of $93.49. The narrow upside suggests limited near-term appreciation potential.
- Gross Margin Pressure: Gross margin declined to 54.96% in Q1 2026 from 56.51% a year ago, indicating input cost inflation or mix shift. Continued pressure could erode profitability.
MNST Technical Analysis
Monster Beverage is in a sustained uptrend, with the stock price up 55.35% over the past year, significantly outperforming the S&P 500's 16.47% gain. The current price of $93.49 sits at 93.2% of its 52-week range ($58.09–$100.34), indicating the stock is trading near its highs, which suggests strong momentum but also potential overextension. This positioning near the top of the range reflects investor optimism but warrants caution for new entries without a pullback. Short-term momentum shows a mixed picture: the 1-month price change is -1.28%, while the 3-month change is +19.51%. The negative 1-month return contrasts with the strong 3-month and 1-year gains, signaling a short-term pullback or consolidation within the broader uptrend. The stock's beta of 0.527 indicates it is significantly less volatile than the market, meaning it tends to move less than the S&P 500, which can be attractive for risk-averse investors but may underperform in strong bull markets. Key technical levels: support at the 52-week low of $58.09 and resistance at the 52-week high of $100.34. A breakout above $100.34 would signal a continuation of the uptrend and could open the door to further gains, while a breakdown below $58.09 would be a bearish signal, though unlikely given the current price. The low beta suggests that any such moves would be less dramatic than the broader market.
Beta
0.53
0.53x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$58-$100
Price range past year
Annual Return
+64.1%
Cumulative gain past year
| Period | MNST Return | S&P 500 |
|---|---|---|
| 1m | -1.0% | +0.2% |
| 3m | +25.0% | +3.7% |
| 6m | +19.3% | +8.0% |
| 1y | +64.1% | +18.2% |
| ytd | +26.5% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MNST Fundamental Analysis
Monster Beverage's revenue trajectory is robust, with Q1 2026 revenue of $2.353 billion, representing a 26.89% year-over-year growth rate. This marks an acceleration from the 13.9% growth seen in Q1 2025 ($1.855 billion) and the 14.1% growth in Q2 2025 ($2.112 billion). The growth is driven by Monster Energy Drinks ($2.189 billion, 93% of total revenue) and Strategic Brands ($126.7 million), while the Alcohol Brands segment remains small at $32.7 million. The accelerating growth trend supports a bullish investment case, though investors should monitor whether this pace is sustainable amid competition. Profitability is strong: net income for Q1 2026 was $569.5 million, with a net margin of 24.2%, up from 23.9% in Q1 2025. Gross margin was 54.96%, slightly down from 56.51% a year ago, indicating some input cost pressure. Operating margin improved to 31.02% from 30.72% in Q1 2025, reflecting operating leverage. The company is highly profitable with expanding margins, which is typical for industry leaders with strong brand pricing power. Monster's balance sheet is pristine: it has zero debt (debt-to-equity ratio of 0) and a current ratio of 3.70, indicating ample liquidity. Free cash flow (TTM) is $2.072 billion, and the company generated $605 million in operating cash flow in Q1 2026 alone. ROE is 23.08%, reflecting efficient capital use. The strong cash generation and zero debt mean Monster can fund growth internally and is well-positioned for acquisitions or share buybacks, reducing financial risk.
Quarterly Revenue
$2.4B
2026-03
Revenue YoY Growth
+26.9%
YoY Comparison
Gross Margin
55.0%
Latest Quarter
Free Cash Flow
$2.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MNST Overvalued?
Since Monster has positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 39.32x, while the forward P/E is 36.02x. The forward discount suggests the market expects earnings growth, which aligns with the company's recent acceleration. The PEG ratio of 1.31x indicates that the stock is reasonably priced relative to its growth rate, though not cheap. Compared to the industry average (beverages - non-alcoholic), Monster's trailing P/E of 39.32x is at a premium to the sector median of roughly 22x, representing a 79% premium. This premium is justified by Monster's superior growth (26.9% revenue growth vs. industry average of ~8%), high margins (net margin 24.2% vs. industry ~15%), and dominant market position. However, the premium also reflects high expectations that must be met. Historically, Monster's trailing P/E has ranged from 30x to 47x over the past five years. The current 39.32x is near the middle of this range, suggesting the stock is not at extreme valuation levels. It is below the 46.9x seen in Q4 2024 but above the 31.2x in Q1 2026. This indicates that the market is pricing in optimistic but not overly aggressive expectations, and the stock could have room to run if growth continues.
PE
39.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 30x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Monster's zero-debt balance sheet and $2.07B free cash flow provide a strong buffer, but the company faces margin pressure from rising input costs, as evidenced by gross margin declining from 56.51% to 54.96% YoY. Revenue concentration in energy drinks (93% of total) exposes the company to category-specific downturns or shifts in consumer preferences. The alcohol segment remains nascent at $32.7M, offering limited diversification. Earnings are dependent on continued growth to justify the premium P/E of 39.32x; any slowdown could trigger de-rating.
Market & Competitive Risks: The stock's 39.32x trailing P/E is a 79% premium to the beverage industry median, making it vulnerable to valuation compression if growth disappoints. Competition from Celsius is intensifying, with Celsius offering higher growth potential and targeting Monster's core demographic. Regulatory risks include potential sugar taxes or marketing restrictions on energy drinks. With a beta of 0.527, the stock is less correlated to the market, but macro headwinds like inflation could still impact consumer spending on premium beverages.
Worst-Case Scenario: If Monster's revenue growth decelerates sharply (e.g., below 10%) due to market share losses to Celsius or a broader economic downturn, the stock could re-rate to a lower multiple. The analyst low target of $70 implies a 25.1% downside from the current price of $93.49. The 52-week low of $58.09 represents a potential 37.9% decline. In a severe scenario, a combination of margin compression and multiple contraction could drive the stock to $58.09, resulting in a loss of approximately 38% for investors buying at current levels.
FAQ
The primary risk is competitive pressure from Celsius, which offers higher growth potential and could erode Monster's market share. Second, the premium valuation (39.32x P/E) leaves the stock vulnerable to multiple compression if growth decelerates. Third, gross margin declined from 56.51% to 54.96% YoY, indicating input cost pressures that could persist. Fourth, the alcohol segment is still small ($32.7M) and unproven, offering limited diversification. The most severe risk is a combination of slowing growth and margin contraction, which could drive the stock down 25-38% to the analyst low target of $70 or 52-week low of $58.09.
Analysts have a consensus 'Buy' rating with an average target of $95.70, implying 2.4% upside. Our 12-month outlook includes a base case (55% probability) with a target range of $90-$100, assuming 15-18% revenue growth and stable margins. The bull case (25% probability) targets $100-$113, driven by sustained 20%+ growth and margin expansion. The bear case (20% probability) targets $70-$85, assuming competition from Celsius accelerates and growth decelerates below 10%. The most likely scenario is the base case, with modest upside from current levels.
Monster's trailing P/E of 39.32x is a 79% premium to the beverage industry median of ~22x, indicating the market is paying a premium for its superior growth and margins. However, the forward P/E of 36.02x and PEG ratio of 1.31x suggest the premium is justified by expected earnings growth. Historically, MNST has traded between 30x and 47x P/E over the past five years, so the current 39.32x is near the middle of that range. The stock appears fairly valued relative to its own history and growth prospects, but not undervalued. The market is pricing in continued double-digit growth and stable margins.
Monster Beverage is a high-quality company with accelerating revenue growth (26.89% YoY) and strong profitability (net margin 24.2%). However, the stock trades at a premium valuation (trailing P/E 39.32x) and analyst targets imply only 2.4% upside. For long-term investors with a horizon of 3-5 years, MNST can be a solid holding given its dominant market position and zero-debt balance sheet. But for short-term traders, the limited near-term upside and recent short-term weakness (down 1.28% in the past month) suggest waiting for a pullback. The biggest downside risk is competition from Celsius, which could pressure growth and margins.
Monster Beverage is better suited for long-term investment due to its strong brand, zero-debt balance sheet, and consistent growth. The low beta of 0.527 indicates lower volatility, making it a defensive growth stock. Short-term trading is less attractive given the modest analyst upside (2.4%) and recent short-term weakness. A minimum holding period of 3-5 years is recommended to allow the compounding of earnings growth and to ride out any competitive or macro headwinds. The stock does not pay a dividend, so total return depends on capital appreciation.
